Evidence map›Paper›PMID 40785938›Full record

ArticleQuantitative imaging in medicine and surgery2025

Superior lesion detection with

Yuxuan Liu, Siqi Li, Baojun Sang, Jun Liu, Yanfeng Xu, Jigang Yang, Xiaorong Sun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuxuan Liu *Department of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Siqi Li *Nuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Baojun SangDepartment of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Jun LiuNuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Yanfeng XuNuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Jigang YangNuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, Beijing, China.ORCID https://orcid.org/0000-0002-0538-7676
Xiaorong SunDepartment of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.ORCID https://orcid.org/0000-0001-8520-9556

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: High-risk neuroblastoma (NB) is characterized by its resistance to treatment and high recurrence rate. Accurate imaging diagnostic methods can improve prognosis. As an emerging and promising diagnostic tool, the comparative diagnostic value of Methods: This retrospective study included 832 pediatric patients presenting with suspected recurrent NB between January 2021 and February 2024. The lesion detection capabilities of Results: The study population comprised 74 pediatric patients diagnosed with and treated for recurrent NB. The Conclusions: The

Indexed as

123I-meta-iodobenzylguanide single-photon emission computed tomography/computed tomography (123I-MIBG SPECT/CT)18F-AlF-NOTA-octreotide positron emission tomography/computed tomography (18F-OC PET/CT)lesion detectionneuroblastoma (NB)

Identifiers

PMID40785938
PMCPMC12332734

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.